Educational Qualification

• PhD, Pharmaceutical and Biomedical Sciences, University of Strathclyde, UK
• BSc in Pharmacy, University of Jordan, Jordan

Experience

• Assistant Vice President – Global Strategy, Industrial Engagement and Business Development, RAK Medical & Health Sciences University, UAE (2026 - Present)
• Professor of Nanomedicine and Drug Delivery, College of Pharmacy, RAK Medical & Health Sciences University, UAE (2025 - Present)
• Professor of Pharmaceutics, Faculty of Pharmacy, Yarmouk University, Jordan (January 2018 - February 2025)
• Vice Dean for Scientific Research and Graduate Studies, Faculty of Pharmacy, Yarmouk University, Jordan
• Director, Technology Transfer Office, Yarmouk University, Jordan
• Chair, Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Jordan
• Academic Visitor, University of Strathclyde, UK (current appointment extended to September 2027)

Courses Taught

• Physical Pharmaceutics and Product Formulation
• Pharmaceutics I and III
• Pharmaceutical Calculations
• Biotechnology I and II
• Novel Drug Delivery Systems
• Advanced Pharmaceutical Biotechnology

Publications

• Nose-to-Brain Nanocarriers for Migraine Management: A Comprehensive Review of Drug Delivery Strategies and Translational Challenges. Current Medical Science, 2026.
• The activity of niosomal serratiopeptidase enzyme in combination with palmitoleic acid in rats with insulin-resistant polycystic ovarian syndrome. Naunyn-Schmiedeberg’s Archives of Pharmacology, 2026.
• Approaches for the delivery of anti-parkinsonian therapeutic agents via the intranasal route. Discover Neuroscience, 2026.
• Exploring the therapeutic potential of NCX1 in hematological cancers; integration of molecular docking, bioinformatics approaches, and experimental validation. Biochemical and Biophysical Research Communications, 2026.

• Drug delivery systems incorporating bile salts: advancements since the conception of bilosomes. Therapeutic Delivery, 2025.
• Nanomaterial-based drug delivery systems in overcoming bacterial resistance: Current review. Microbial Pathogenesis, 2025.
• Phytochemicals in Cancer Therapy: A Structured Review of Mechanisms, Challenges, and Progress in Personalized Treatment. Chemistry & Biodiversity, 2025.
• Inflammation-driven Oncogenesis: Precision Medicine and Immunotherapeutic Strategies. Mini-Reviews in Medicinal Chemistry, 2025.
• Silencing c-myc gene by siRNA delivered by cationic niosomes in MCF-7 cells. Journal of Pharmacy and Pharmacology, 2025.
• Small non-coding RNAs as therapeutic targets with delivery strategies in cancer treatment and their clinical applications. International Journal of Pharmaceutics, 2025.
• Preclinical toxicological evaluation of adjunct dementia medicinal supplement (PMCV002) in Wistar rats: from bench to clinical trial series. 2025.

• Characterisation of ciprofloxacin-loaded polymeric fiber mats prepared by melt electrospinning. Macromolecular Materials and Engineering, 2024.
• Paclitaxel-loaded niosomes in combination with metformin: development, characterization and anticancer potentials. Therapeutic Delivery, 2024.
• Formulation of polycaprolactone meshes by melt electrospinning for controlled release of daunorubicin in tumour therapy. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2024.
• Nanomaterial-Driven Precision Immunomodulation: A New Paradigm in Therapeutic Interventions. Cancers, 2024.
• Customizable Microfluidic Devices: Progress, Constraints, and Future Advances. Current Drug Delivery, 2024.
• Microfluidic Manufacturing of Niosomes. In: Microfluidics in Pharmaceutical Sciences, Academic Press, 2024.
• FastTrack Vaccine Development for COVID-19 and Impact of Emerging Variants. In: SARS-CoV-2 Variants and Global Population Vulnerability, 2024.

• The impact of solvent selection on the characteristics of niosome nanoparticles prepared by microfluidic mixing. International Journal of Pharmaceutics: X, 2023.
• Nanomaterials and Their Impact on the Immune System. International Journal of Molecular Sciences, 2023.
• Recent updates in curcumin delivery. Journal of Liposome Research, 2023.
• Recent Advances in Photothermal Therapies Against Cancer and the Role of Membrane Transporter Modulators on the Efficacy of This Approach. Technology in Cancer Research & Treatment, 2023.
• Formulation and evaluation of nanosized hippadine-loaded niosome: extraction and isolation, physicochemical properties, and in vitro cytotoxicity against human ovarian and skin cancer cell lines. Journal of Drug Delivery Science and Technology, 2023.
• The effect of polymeric films of hydroxypropyl methylcellulose (HPMC)/chitosan on ofloxacin release, diffusion, and biological activity. Polymer Engineering & Science, 2023.
• Innovations in liposomal drug delivery: paving the way for personalized cancer therapy. Book chapter, Elsevier, 2023.
• The Next Generation of Drug Delivery: Harnessing the Power of Bacteriophages. Book chapter, Springer, 2023.

• Mucosal and systemic immune responses following mucosal immunisation of tetanus toxoid entrapped in lipid nanoparticles prepared by microwave reactor. European Journal of Pharmaceutics and Biopharmaceutics, 2022.
• SARS-CoV-2: vaccinology and emerging therapeutics; challenges and future developments. Therapeutic Delivery, 2022.
• Synthesis, characterization, and assessment of anti-cancer potential of ZnO nanoparticles in an in vitro model of breast cancer. Molecules, 2022.
• Monkeypox: Emerging virus of concern; antivirals and vaccines therapeutic options. Microbial Pathogenesis, 2022.
• Characterisation of niosome nanoparticles prepared by microfluidic mixing for drug delivery. International Journal of Pharmaceutics: X, 2022.
• Lipid-Based Nanomaterials in Cancer Treatment and Diagnosis. In: Bionanotechnology, Bentham Science Publishers, 2022.

• Potentiality of Melittin-Loaded Niosomal Vesicles Against Vancomycin-Intermediate Staphylococcus aureus and Staphylococcal Skin Infection. International Journal of Nanomedicine, 2021.
• Use of Nanoparticles in Delivery of Nucleic Acids for Melanoma Treatment. Methods in Molecular Biology, 2021.
• siRNA Delivery to Melanoma Cells with Cationic Niosomes. Methods in Molecular Biology, 2021.
• Latest advances in triple-negative breast cancer nanotheranostics. Book chapter, 2021.
• Targeting siRNAs in cancer drug delivery. Book chapter, Academic Press/Elsevier, 2021.
• Nanocelluloses as a Novel Vehicle for Controlled Drug Delivery. Book chapter, Springer, 2021.
• Stem Cell-Based Products in the Market. Book chapter, Elsevier, 2021.

Achievements

• Invited Speaker, Emirates Pharmacy Society Conference, 2026: “Personalized Medicine and Emerging Technologies: Transforming the Future of Healthcare.”
• Guest Editor, Frontiers in Pharmacology, 2026–2027, for the Research Topic “Novel Technologies for Enhancing the Bioavailability, Permeability, and Therapeutic Performance of Biologics and Advanced Therapeutics.”
• Secured multiple competitive research grants with a cumulative value exceeding USD 160,000, supporting research in nanomedicine, advanced drug delivery systems, microfluidics, and pharmaceutical sciences.
• Research impact: author of more than 90 peer-reviewed publications, with 2,150+ citations and an h-index of 30 (Google Scholar).